Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Abstract PO3-05-11: Enhancing the interpretation of real-world quality of life (QoL) in patients (pts) with hormone receptor positive human epidermal growth factor 2 negative (HR+/HER2−) advanced breast cancer (ABC) enrolled in the POLARIS trial

Gabrielle Rocque, Joanne Blum, Yan Ji, Timothy Pluard, John Migas, Shailendra Lakhanpal, Erin Jepsen, Eric Gauthier, Yao Wang, Monica Montelongo, Joseph C. Cappelleri, Connie Chen, Meghan Karuturi, Debu Tripathy

Cancer Res (2024) 84 (9_Supplement): PO3-05-11.

https://doi.org/10.1158/1538-7445.SABCS23-PO3-05-11

Published: 02 May 2024

View article titled, Abstract PO3-05-11: Enhancing the interpretation of real-world quality of life (QoL) in patients (pts) with hormone receptor positive human epidermal growth factor 2 negative (HR+/HER2−) advanced breast cancer (ABC) enrolled in the POLARIS trial

Journal Articles

Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer

Fatima Cardoso, William Jacot, Sherko Küemmel, Sudeep Gupta, Rama Balaraman, Liudmila Lebedeva, Yan Ji, Aparna Lakshmanan, Khalid Amin, Zheng Li, Joseph Sparano

Cancer Res (2023) 83 (5_Supplement): PD17-12.

https://doi.org/10.1158/1538-7445.SABCS22-PD17-12

Published: 01 March 2023

View article titled, Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer

Journal Articles

Abstract PS13-16: Pharmacokinetic evaluation of an oral paclitaxel DHP107 (Liporaxel^®) in patients with recurrent or metastatic breast cancer (MBC): Phase II study (OPERA, NCT03326102)

Hope S Rugo, Timothy J Pluard, Priyanka Sharma, Michelle Melisko, Ghassan Al-Jazayrly, Neelima Vidula, Yan Ji, David Weng, Hyeong-Seok Lim, Koung Eun Yoon, Hyun Ju Cho

Cancer Res (2021) 81 (4_Supplement): PS13-16.

https://doi.org/10.1158/1538-7445.SABCS20-PS13-16

Published: 15 February 2021

View article titled, Abstract PS13-16: Pharmacokinetic evaluation of an oral paclitaxel DHP107 (Liporaxel®) in patients with recurrent or metastatic breast cancer (MBC): Phase II study (OPERA, NCT03326102)

Journal Articles

Abstract P1-19-37: Pharmacokinetic assessment of ribociclib, an oral CDK4/6 inhibitor, and the interaction with endocrine therapy partners in patients with advanced breast cancer

Yan Ji, Tanay Samant, Michelle Quinlan, Abhijit Chakraborty

Cancer Res (2020) 80 (4_Supplement): P1-19-37.

https://doi.org/10.1158/1538-7445.SABCS19-P1-19-37

Published: 15 February 2020

View article titled, Abstract P1-19-37: Pharmacokinetic assessment of ribociclib, an oral CDK4/6 inhibitor, and the interaction with endocrine therapy partners in patients with advanced breast cancer

Journal Articles

Abstract PD7-09: A phase 1/1b study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib in patients with estrogen receptor-positive (ER+) advanced breast cancer (ABC) who had progressed after endocrine therapy (ET)

Komal Jhaveri, Dejan Juric, Sara Cresta, Yoon-Sim Yap, Francois P Duhoux, Catherine Terret, Rachel Layman, Nicole Kundamal, Serena Liao, Yan Ji, Adam Crystal, Giuseppe Curigliano

Cancer Res (2020) 80 (4_Supplement): PD7-09.

https://doi.org/10.1158/1538-7445.SABCS19-PD7-09

Published: 15 February 2020

View article titled, Abstract PD7-09: A phase 1/1b study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib in patients with estrogen receptor-positive (ER+) advanced breast cancer (ABC) who had progressed after endocrine therapy (ET)

Journal Articles

Abstract CT175: Biomarker analyses from a phase I study of WNT974, a first-in-class Porcupine inhibitor, in patients (pts) with advanced solid tumors

Jordi Rodon, Guillem Argilés, Roisin M. Connolly, Ulka Vaishampayan, Maja de Jonge, Elena Garralda, Marios Giannakis, David C. Smith, Jason R. Dobson, Margaret McLaughlin, Abdelkader Seroutou, Yan Ji, Sinead Dolan, Jennifer Morawiak, Susan Moody, Filip Janku

Cancer Res (2018) 78 (13_Supplement): CT175.

https://doi.org/10.1158/1538-7445.AM2018-CT175

Published: 01 July 2018

View article titled, Abstract CT175: Biomarker analyses from a phase I study of WNT974, a first-in-class Porcupine inhibitor, in patients (pts) with advanced solid tumors

Journal Articles

Abstract #2981: Anti-inflammatory action of pterostilbene is mediated through the p38-ATF2 pathway in colon cancer cells

Shiby Paul, Agnes Rimando, Hong Lee, Yan Ji, Bandaru Reddy, Nanjoo Suh

Cancer Res (2009) 69 (9_Supplement): 2981.

Published: 01 May 2009

View article titled, Abstract #2981: Anti-inflammatory action of pterostilbene is mediated through the p38-ATF2 pathway in colon cancer cells

Journal Articles

Abstract 2097: Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Hong Jin Lee, Shiby Paul, Yan Ji, Nadi Atalla, Paul E Thomas, Hubert Maehr, Milan Uskokovic, Nanjoo Suh

Cancer Res (2008) 68 (9_Supplement): 2097.

https://doi.org/10.1158/1538-7445.AM2008-2097

Published: 15 May 2008

View article titled, Abstract 2097: Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Journal Articles

Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Hong Jin Lee, Shiby Paul, Yan Ji, Nadi Atalla, Paul Thomas, Hubert Maehr, Milan Uskokovic, Nanjoo Suh

Cancer Res (2008) 68 (9_Supplement): 2097.

Published: 01 May 2008

View article titled, Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Journal Articles

Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D₃ Analogue Is Mediated by Ras/Protein Kinase Cα

Hong Jin Lee, Yan Ji, Shiby Paul, Hubert Maehr, Milan Uskokovic, Nanjoo Suh

Cancer Res (2007) 67 (24): 11840–11847.

https://doi.org/10.1158/0008-5472.CAN-07-1549

Published: 18 December 2007

View article titled, Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D3 Analogue Is Mediated by Ras/Protein Kinase Cα

Journal Articles

Activation of bone morphogenetic protein signaling by a novel vitamin D3 analog is mediated through Ras and protein kinase Cα pathway in MCF10 breast epithelial cells

Hong Jin Lee, Yan Ji, Shiby Paul, Hubert Maehr, Milan Uskokovic, Nanjoo Suh

Cancer Res (2007) 67 (9_Supplement): 2519.

Published: 01 May 2007

View article titled, Activation of bone morphogenetic protein signaling by a novel vitamin D3 analog is mediated through Ras and protein kinase Cα pathway in MCF10 breast epithelial cells

Journal Articles

Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats: a pilot study

Nanjoo Suh, Shiby Paul, Hong Jin Lee, Yan Ji, Mao-Jung Lee, Chung Yang, Bandaru Reddy, Harold Newmark

Cancer Res (2007) 67 (9_Supplement): 2495.

Published: 01 May 2007

View article titled, Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats: a pilot study

Journal Articles

Gene expression profile changes induced by a novel Gemini vitamin D3 analog during the progression of breast cancer

Hong Jin Lee, Hao Liu, Catherine Goodman, Yan Ji, Hubert Maehr, Milan Uskokovic, Daniel Notterman, Michael Reiss, Nanjoo Suh

Cancer Res (2006) 66 (8_Supplement): 979–980.

Published: 15 April 2006

View article titled, Gene expression profile changes induced by a novel Gemini vitamin D3 analog during the progression of breast cancer

Journal Articles

A synthetic triterpenoid CDDO-Im induces monocytic differentiation by activating Smad signaling pathway in HL60 leukemia cells

Yan Ji, Hong Jin Lee, Catherine Goodman, Milan Uskokovic, Karen Liby, Michael Sporn, Nanjoo Suh

Cancer Res (2006) 66 (8_Supplement): 571.

Published: 15 April 2006

View article titled, A synthetic triterpenoid CDDO-Im induces monocytic differentiation by activating Smad signaling pathway in HL60 leukemia cells

Journal Articles

Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein β Are Required for 1,25-Dihydroxyvitamin D₃-Induced Monocytic Differentiation of HL60 Cells

Yan Ji, George P. Studzinski

Cancer Res (2004) 64 (1): 370–377.

https://doi.org/10.1158/0008-5472.CAN-03-3029

Published: 16 January 2004

View article titled, Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein β Are Required for 1,25-Dihydroxyvitamin D3-Induced Monocytic Differentiation of HL60 Cells

NARROW

Abstract PO3-05-11: Enhancing the interpretation of real-world quality of life (QoL) in patients (pts) with hormone receptor positive human epidermal growth factor 2 negative (HR+/HER2−) advanced breast cancer (ABC) enrolled in the POLARIS trial

Abstract PD17-12: Primary efficacy and safety results from the AMALEE trial evaluating 600 mg vs 400 mg starting doses of first-line ribociclib in patients with HR+/HER2− advanced breast cancer

Abstract PS13-16: Pharmacokinetic evaluation of an oral paclitaxel DHP107 (Liporaxel^®) in patients with recurrent or metastatic breast cancer (MBC): Phase II study (OPERA, NCT03326102)

Abstract P1-19-37: Pharmacokinetic assessment of ribociclib, an oral CDK4/6 inhibitor, and the interaction with endocrine therapy partners in patients with advanced breast cancer

Abstract PD7-09: A phase 1/1b study of LSZ102, an oral selective estrogen receptor degrader (SERD), in combination with ribociclib in patients with estrogen receptor-positive (ER+) advanced breast cancer (ABC) who had progressed after endocrine therapy (ET)

Abstract CT175: Biomarker analyses from a phase I study of WNT974, a first-in-class Porcupine inhibitor, in patients (pts) with advanced solid tumors

Abstract #2981: Anti-inflammatory action of pterostilbene is mediated through the p38-ATF2 pathway in colon cancer cells

Abstract 2097: Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Gemini vitamin D analogs inhibit estrogen receptor positive and estrogen receptor negative mammary tumorigenesis without hypercalcemic toxicity

Activation of Bone Morphogenetic Protein Signaling by a Gemini Vitamin D₃ Analogue Is Mediated by Ras/Protein Kinase Cα

Activation of bone morphogenetic protein signaling by a novel vitamin D3 analog is mediated through Ras and protein kinase Cα pathway in MCF10 breast epithelial cells

Mixed tocopherols inhibit N-methyl-N-nitrosourea-induced mammary tumorigenesis in rats: a pilot study

Gene expression profile changes induced by a novel Gemini vitamin D3 analog during the progression of breast cancer

A synthetic triterpenoid CDDO-Im induces monocytic differentiation by activating Smad signaling pathway in HL60 leukemia cells

Retinoblastoma Protein and CCAAT/Enhancer-Binding Protein β Are Required for 1,25-Dihydroxyvitamin D₃-Induced Monocytic Differentiation of HL60 Cells

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only